Maynard Lab

The Maynard Lab at UT Austin develops protein therapeutics and vaccines to address unmet medical needs in cancer and infectious diseases.

[Maynard Lab @maynard_lab]

We used this opportunity to get a very silly (and great) photo of team “we’re coming for you, CMV!” 😁 It’s a fantastic group ready to battle this common pathogen. Big congratulations to its most senior member!!

[Maynard Lab @maynard_lab]

Congratulations on a great Ph.D. defense, Dr. Laura Azouz @lauraazouz !! Laura discussed her investigation of the peptide specificity of an affinity matured TCR that targets cytomegalovirus’ pp65 peptide. @TexasChE

[Maynard Lab @maynard_lab]

In addition to substantial contributions to CMV targeting efforts in progress, she’s published very nice work on antibodies that bind myocilin: https://t.co/jaqClEFfZa Laura also has incredible skill in teaching and has made a big impact on many UT undergrads during her PhD!

[Maynard Lab @maynard_lab]

AND we met baby goats and big rabbits at the “Clock Knot” sculpture and “Monochrome for Austin” canoes through Paws for Publuc Art @LandmarksUT. Truly a lovely day to be @TexasLonghorns!

[Maynard Lab @maynard_lab]

A beautiful day at @TexasChE for a new lab photo!

[Maynard Lab @maynard_lab]

We also finally got to meet Susan Marqusee from the @MarquseeLab in person today and enjoyed a wonderful talk from her on protein dynamics and folding!

[Maynard Lab @maynard_lab]

This has been a great collaboration on an incredibly interesting and difficult virus, CMV. The manuscript includes outstanding work from ILS grad student Alison Lee, who developed our CMV neutralization assay and applied it to a large number of samples with quick turnaround!

[Jason McLellan @McLellan_Lab]

Excited to share the pre-print describing our efforts to stabilize the HCMV gB ectodomain in a prefusion-like conformation. We and others have now routinely stabilized class I viral fusion proteins, but class III viral fusogens have been more difficult.

[Maynard Lab @maynard_lab]

Congrats on an incredibly successful internship to @Ines_S_Pinto who visited us for a few months from @cnc_uc ! She quickly learned all we could teach her and has a very bright future ahead. Many thanks to the @UTPortugal @CockrellSchool program. We will miss you, Ines!!

[Maynard Lab @maynard_lab]

Oh my goth, it’s Halloween in the Maynard Lab! 👻

[Maynard Lab @maynard_lab]

The Advanced Protein Therapeutics Core Facility in the Maynard Lab is looking for an early stage post-doc to join us! Please share and find more info here: https://t.co/8uXsm0D10q

[Maynard Lab @maynard_lab]

Our Advanced Protein Therapeutics Core had a great time last week with our Short Course on Antibody Phage Panning! Many thanks to the participants for all of the "phun" with phage! Keep up with the APT core and future offerings on our website: https://t.co/se9RfOozky

[TexasChE @TexasChE]

Check out @TexasChE Professor Lydia Contreras, @Contreras_Lab, in #ItStartsWithResearch premiere episode from @UTexasResearch.

@CockrellSchool

[Maynard Lab @maynard_lab]

Check out some of Dzifa's very cool work (with more to come) helping us understand the role of ACT and pertactin in pertussis pathogenesis here:
https://t.co/diPg2fWWlx
https://t.co/XiwgQNVv5N

[Maynard Lab @maynard_lab]

We are so happy to congratulate Dr. Dzifa Amengor on her outstanding PhD defense! Dzifa has been such an impactful researcher and wonderful group member in our lab. We will miss her so much!

[Maynard Lab @maynard_lab]

Dzifa is actively entertaining offers in the biotech and therapeutic development industries. She is so adept and sharp and will be an incredible asset to whoever is lucky enough to work with her! https://t.co/AgZtSew6pA

[TexasChE @TexasChE]

Feel good piece. 6 min read. @TexasChE students reflect on their recent May Terms abroad. https://t.co/5CZfP7eGVn

@brian_korgel @maynard_lab @CockrellSchool

[Maynard Lab @maynard_lab]

We’re so proud of you, @ahlamqerqez !

[TexasChE @TexasChE]

Ahlam Qerqez, Ph.D. 2022 @TexasChE, to attend the upcoming 72nd Lindau Nobel Laureate Meeting with the 2020 cohort of Young Scientists. More on her work and this prestigious event: https://t.co/FycdyAuqls
#LINO23 @CockrellSchool

[Jason McLellan @McLellan_Lab]

It's an incredible day for structure-based vaccine design, and I'm thrilled to see our prefusion RSV F antigen get approved as the first RSV vaccine. Still more work to do to reduce the RSV disease burden, but this will help! Congrats @BarneyGrahamMD! https://t.co/8L5JaNy49o

[Maynard Lab @maynard_lab]

Dr. Kevin Entzminger, former Maynard Lab rockstar, has new outstanding work out on cross-reactive SARS-CoV-2 spike directed antibodies with his team @AbwizBio - check it out! https://t.co/XTY6hkEdOE

[Maynard Lab @maynard_lab]

Thank you to @ojaldridge for doing an awesome job describing our latest SARS-CoV-2 work towards pancoronavirus vaccines and therapies for @KUT!

[Olivia Aldridge @ojaldridge]

I am once again bringing the term "spike protein" back into your life. A team at UT found a component all known coronaviruses have in common. It's not prone to mutation, so by targeting it, researchers hope they can create universal coronavirus treatments. https://t.co/b2ZkziyR4P